Skip to content

Assessment of Ozone Therapy for Management of Post-Extraction Localized Alveolar Osteitis

Management of Post-Extraction Localized Alveolar Osteitis

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07106333
Enrollment
40
Registered
2025-08-06
Start date
2025-08-01
Completion date
2026-02-01
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Osteitis

Brief summary

This clinical study investigates the effectiveness of ozone therapy in comparison to conventional treatment for alveolar osteitis (AO), a common painful complication following tooth extraction. Forty patients diagnosed with dry socket will be randomly divided into two groups. Group A will receive traditional treatment with normal saline irrigation and analgesics, while Group B will be treated using ozonated water, ozonated gel, and analgesics. Both groups will be monitored over a two-week period to evaluate pain levels, healing progression, and other clinical indicators. The study aims to assess the palliative and regenerative benefits of ozone therapy in managing AO, potentially offering an alternative to conventional symptomatic treatments.

Detailed description

Alveolar osteitis (AO), commonly referred to as dry socket, is a frequent postoperative complication following tooth extraction. It typically presents 1-3 days post-extraction with severe pain due to premature loss or breakdown of the blood clot within the extraction socket. While the exact pathogenesis remains controversial, enhanced fibrinolytic activity, bone trauma, and bacterial contamination are considered primary contributing factors. The incidence is notably higher in mandibular third molars. Traditional management approaches-such as saline irrigation, antibiotics, and eugenol-based dressings-are often palliative and do not directly target the underlying cause. Ozone therapy, with its antimicrobial, analgesic, and wound-healing properties, has recently emerged as a potential alternative. Ozone, when applied in water or gel forms, is believed to promote clot stability, reduce pain, and enhance soft tissue regeneration. Aim of the Study: To assess and compare the palliative (pain-relieving) and regenerative (healing-promoting) effects of ozone therapy versus conventional treatment in patients suffering from alveolar osteitis.

Interventions

The intervention involves local application of ozone in two forms: Ozonated Water - used for irrigation of the extraction socket. Ozonated Gel - applied topically inside the socket to promote healing and reduce pain. Both are used after socket debridement and bleeding provocation, followed by standard analgesic administration (Diclofenac potassium).

OTHERIrrigation with saline

The intervention involves irrigation with saline

Sponsors

Menoufia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

intervention after wisdom tooth extraction either with saline or with topical ozone

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Age: 18-60 years. Patients undergoing simple (non-surgical) extractions. Medically healthy individuals.

Exclusion criteria

Patients already treated for AO. Presence of systemic diseases affecting healing. Severe infections or facial swelling. Incomplete follow-up. Contraindications to ozone therapy: G6PD deficiency, hyperthyroidism, malignant hypertension, recent myocardial infarction.

Design outcomes

Primary

MeasureTime frameDescription
Pain ReductionPain intensity will be recorded at: Day 2 Day 3 Day 7 Day 10 Day 14Patient-reported pain scale, categorized as: Severe Moderate Mild No pain

Contacts

Primary ContactMohammed A. El-Sawy, PhD
Dr_sawy@windowslive.com00201061314522
Backup ContactMohammed T. Khater, PhD
MohamedKhaterdentalsmile1234@gmail.com00201003854552

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026